Clinical Trial Update: High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a high-protein oral supplement containing liposomal curcumin in adults undergoing hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Liposomal Curcumin (curcumin liposomal formulation)

Snippet

Sponsor: University of Florida | Conditions: Chronic Kidney Disease 5D | Phase 3 | Status: COMPLETED